A subscription to JoVE is required to view this content. Sign in or start your free trial.
* These authors contributed equally
This study describes a combined magnetic resonance imaging (MRI) and low-intensity pulsed focused ultrasound (FUS) protocol, utilizing living rats with jugular vein catheterization to monitor blood-brain barrier (BBB) opening.
The brain has a highly selective semipermeable blood barrier, termed the blood-brain barrier (BBB), which prevents the delivery of therapeutic macromolecular agents to the brain. The integration of MR-guided low-intensity pulsed focused ultrasound (FUS) with microbubble pre-injection is a promising technique for non-invasive and non-toxic BBB modulation. MRI can offer superior soft-tissue contrast and various quantitative assessments, such as vascular permeability, perfusion, and the spatial-temporal distribution of MRI contrast agents. Notably, contrast-enhanced MRI techniques with gadolinium-based MR contrast agents have been shown to be the gold standard for detecting BBB openings. This study outlines a comprehensive methodology involving MRI protocols and animal procedures for monitoring BBB opening in a rat model. The rat model provides the added benefit of jugular vein catheter utilization, which facilitates rapid medication administration. A stereotactic-guided preclinical FUS transducer facilitates the refinement and streamlining of animal procedures and MRI protocols. The resulting methods are characterized by reproducibility and simplicity, eliminating the need for specialized surgical expertise. This research endeavors to contribute to the optimization of preclinical procedures with rat models and encourage further investigation into the modulation of the BBB to enhance therapeutic interventions in neurological disorders.
The BBB regulates the movement of ions, molecules, and cells between the blood vessels and brain tissues1. This function allows the maintenance of neuronal function and health while preventing the delivery of therapeutic macromolecular agents to the brain tissues. The limited permeability of the BBB can result in decreasing the efficacy and effectiveness of treatments for brain tumors and neurodegenerative diseases, such as Parkinson's disease, amyotrophic lateral sclerosis, and Alzheimer's disease2. Hence, various approaches, such as convection-enhanced delivery, direct intracranial injections, osmotic disruptio....
All animal experiments in this study were approved by the University of California, San Francisco (UCSF) Institutional Animal Care and Use Committee (IACUC). Male Sprague-Dawley rats (200-250 g) were used in this study. Rats were housed and cared for according to the National Institutes of Health Office of Animal Care and Use Guidelines in mice and rats. The details of the reagents and the equipment used are listed in the Table of Materials.
1. Animal preparation
This study presents a preclinical protocol for monitoring BBB opening in a rat model using a commercial animal FUS system. The FUS system was set up on a bench or large cart carrier (Figure 1). Rats were anesthetized with isoflurane mixed with oxygen through the nose cone in the frame with the transducer holder. A hydrophone resonating at 500 kHz for detecting acoustic cavitation was inserted into the FUS transducer with a resonant frequency of 1.0 MHz.
As shown i.......
A protocol and animal procedure using a rat model of jugular vein catheterization for BBB opening studies has been developed. While numerous preclinical protocols exist, this protocol incorporates a commercially available FUS system and a rat model, minimizing animal preparation procedures and thereby ensuring experimental reproducibility.
In this protocol, microbubble selection was based on its stability and room temperature storage. Other commercial microbubbles may be considered as alternat.......
This study was partially supported by the National Institute of Dental and Craniofacial Research (NIDCR) Grant K99DE032397, UCSF Department Seed Grant (No. 7504831), UCSF RAP grant (PI: Kazim Narsinh, MD), and the German Research Foundation (DFG, GA 3535/1-1).
....Name | Company | Catalog Number | Comments |
1 mL syringe | BD plastipak | ||
20 mL, Sodium Chloride 0.9% | Hospira, Inc | 00409-7101-67 | |
3 mL syringe | BD plastipak | ||
5 mL syringe | BD plastipak | ||
Blunt Needle, 21 G | SAI infusion technologies | B21-50 | |
Catheter connector, 21 G | SAI infusion technologies | CC-25-25 | |
Catheter lock solution | SAI infusion technologies | Sku # HGS-10 | (500 µ/mL) Glycerol |
Evans Blue | Sigma aldrich | E2129-10g | |
ExAblate Neuro | Insightec Inc., Israel | ||
Gadavist | Bayer | 2068062 | |
GE isoflurane Vaporizer | GE Healthcare | ||
IPS-12RS Syringe Pump | Inovenso | IPS-12 | |
isoflurane USP | Vet one | 501017 | |
Lumason microbbuble | Bracco Diagnostics Inc | SKJ709700 | |
Male Sprague-Dawley rats (200–250 g) | Charles River Laboratories | ||
Needle, 18 G | BD Precisionglide | ||
Phosphate-buffered saline | Mediatech | 21-030-CVR | |
Polyethylene Tubing | BD Intramedic | ||
preclinical 3T cryogen-free Bruker Biospin scanner | Bruker | Biospec3T | |
Rat with jugular vein catheterization | Charles River Laboratories | ||
RK-50 focused ultrasound transducer | FUS Instruments | Tx-50-1000-0 | |
RK-50 benchtop focused ultrasound system | FUS Instruments | ||
Sonic Concepts | Sonic Concepts Inc., WA, USA | ||
vented dispensing pin | B Braun | 4550560 |
Explore More Articles
This article has been published
Video Coming Soon
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved